Table 4:
None | Mild | Moderate | Severe | |
---|---|---|---|---|
Aspergillus*, n(%) | 66 (53.6) | 15 (35.7) | 18 (52.9) | 13 (52) |
CMV*, n (%) | 80 (64) | 26 (61.9) | 25 (73.5) | 18 (72) |
Gram Negative**, n(%) | 71 (56.8) | 19 (45.2) | 23 (67.6) | 18 (72) |
Gram Positive^, n(%) | 33 (26.4) | 12 (28.6) | 12 (35.3) | 14 (56) |
No Overall significant comparisons for aspergillus or CMV infection
Severe vs Mild (OR 3.11, 95% CI 1.07–9.02, p=0.033) and Moderate vs Mild (OR 2.78, 95% CI 1.07–7.27, p=0.034) had significantly higher rate of gram-negative infection.
Severe patients had significantly higher rate of gram-positive infection than none (OR 2.89, 95% CI 1.25–6.69, p=0.011) and mild (OR 3.18, 95% CI 1.13–8.96, p=0.026) neutropenia patients.